Financial statements Laboratorium Farmaceutyczne Avena

Balance sheet of Laboratorium Farmaceutyczne Avena

Company age:
Age:
8 y. 11 m. 23 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of LABORATORIUM FARMACEUTYCZNE AVENA

Year
2018
2019
2020
2021
2022
2023
Total assets 4 855 222,55 5 639 789,78 8 285 998,03 9 446 395,18 10 254 813,81 10 245 385,20
A. Fixed assets 1 113 487,72 1 563 247,16 3 401 950,88 3 361 381,71 3 414 121,61 2 700 528,92
B. Current assets 3 741 734,83 4 076 542,62 4 884 047,15 6 085 013,47 6 840 692,20 7 544 856,28
C. Share capital contributions (basic funds) - - - - - -
D. Own shares (stocks) - - - - - -
Total liabilities 4 855 222,55 5 639 789,78 8 285 998,03 9 446 395,18 10 254 813,81 10 245 385,20
A. Equity 3 501 708,80 4 058 777,61 5 835 837,81 7 015 415,35 9 097 753,07 9 618 091,08
B. Liabilities and provisions for liabilities 1 353 513,75 1 581 012,17 2 450 160,22 2 430 979,83 1 157 060,74 627 294,12
I. Long-term liabilities 587 278,00 531 254,00 1 268 830,00 1 051 606,00 0,00 0,00
II. Short-term liabilities 763 469,75 1 047 688,17 1 179 956,22 1 378 695,83 1 157 060,74 627 294,12
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.